Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology

@article{OBrien2017ClinicalPW,
  title={Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology},
  author={J. O'Brien and C. Holmes and M. Jones and R. Jones and G. Livingston and I. McKeith and P. Mittler and P. Passmore and C. Ritchie and L. Robinson and E. Sampson and J. Taylor and A. Thomas and A. Burns},
  journal={Journal of Psychopharmacology},
  year={2017},
  volume={31},
  pages={147 - 168}
}
  • J. O'Brien, C. Holmes, +11 authors A. Burns
  • Published 2017
  • Psychology, Medicine
  • Journal of Psychopharmacology
  • The British Association for Psychopharmacology coordinated a meeting of experts to review and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As before, levels of evidence were rated using accepted standards which were then translated into grades of recommendation A–D, with A having the strongest evidence base (from randomised controlled trials) and D the weakest (case studies or expert opinion). Current clinical diagnostic criteria for dementia have… CONTINUE READING
    138 Citations
    Anti-dementia medications: current prescriptions in clinical practice and new agents in progress
    • 27
    • PDF
    Management of mild cognitive impairment (MCI): The need for national and international guidelines
    • S. Kasper, C. Bancher, +7 authors M. S. M. Palomo
    • Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2020
    • 7
    Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
    • 6
    • Highly Influenced

    References

    SHOWING 1-10 OF 271 REFERENCES
    Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
    • 121
    • PDF
    Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
    • 145
    Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
    • 574
    • PDF